单位:[1]Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing[2]Department of Rheumatology and Immunology, Shanxi Medical University Second Hospital, Taiyuan[3]Department of Rheumatology and Immunology, Beijing Hospital[4]Department of Rheumatology and Immunology, China-Japan Friendship Hospital[5]Department of Rheumatology and Immunology,Peking University First Hospital, Beijing[6]Department of Rheumatology and Immunology, Peking University First Hospital, Beijing[7]Department of Rheumatology and Immunology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou广东省人民医院[8]Department of Rheumatology and Clinical Immunology, The First Hospital, China Medical University, Shenyang[9]Department of Rheumatology and Clinical Immunology, SUN Yat-sen Memorial Hospital of SUN Yat-sen University, Guangzhou中山大学附属第二医院[10]Department of Rheumatology and Immunology, The First Affiliated Hospital of Baotou Medical College, Baotou内蒙古科技大学包头医学院[11]Department of Immunology and Rheumatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology,Wuhan华中科技大学同济医学院附属同济医院[12]Department of Rheumatology and Clinical Immunology, Affiliated Hospital of Inner Mongolia Medical College, Hohhot[13]Department of Rheumatology and Clinical Immunology, General Hospital of Tianjin Medical University, Tianjin[14]Department of Rheumatology and Immunology, The Affiliated Hospital of Medical College Qingdao University, Qingdao[15]Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School[16]Department of Rheumatology and Clinical Immunology, Jiangsu Provincial People’s Hospital, Nanjing[17]Department of Stomatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College[18]Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People’s Republic of China
The epidemiological characteristics of Sjogren syndrome (SS) are significantly varied in different countries. We conducted the present study to survey the epidemiological characteristics of primary SS in China. We recruited 483 primary SS patients from 16 Chinese medical centers nationwide from January 2009 to November 2011 and assessed salivary and lacrimal gland dysfunction, organ involvement, and autoimmunity in these patients. The cohort included 456 women and 27 men (ratio, 17:1; mean age at onset, 42 +/- 11 years; median age at diaposis, 49 years; range, 41-56 years). Male patients showed a lower frequency of xerophthalmia (37.0% vs 60.7%) and a higher frequency of arthritis (40.7% vs 16.4%). Young-onset patients showed a higher frequency of low C3 levels (57.7% vs 36.3%) and pancytopenia (22.2% vs 8.8 A). Patients with systemic involvement had a higher frequency of immunoglobulin A (IgA) (39.4% vs 22.5%) and immunoglobulin M (10,1) (12.4% vs 37.9%). Patients with pulmonary involvement had a higher parotid enlargement (21.4% vs 10.2%), purpura (12.1% vs 5.7%) and higher anti-La/SS-B (61.7% vs 41.8%), immunoglobulin G (IgG) (80.7% vs 64.6%) and IgA (48.9% vs 30.6%) levels. Patients with anti-Ro/SSA antibodies had more frequent exocrine gland symptoms and some extraglandular symptoms and immunological alterations. Compared with previous studies performed in other countries, SS patients in China showed particular clinical manifestation, systemic involvement, and immunological alterations.
基金:
Research Special Fund for Public Welfare Industry of Health [201202004]; National Science Technology Pillar Program in the 11th Five-Year Plan [2008BAI59B03]; National Program on Key Research Project of New Drug Innovation [2012ZX09303006-002]; Knowledge Innovation Program of the Chinese Academy of SciencesChinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-8]; CAS/SAFEA International Partnership Program for Creative Research TeamsChinese Academy of Sciences [Y2CX131003]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81072486, 81172857, 81101545]
第一作者单位:[1]Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing
共同第一作者:
通讯作者:
通讯机构:[1]Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing[*1]Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, No. 41 Da Mu Cang, Western District, Beijing 100032, China
推荐引用方式(GB/T 7714):
Yun Zhao,Ya Li,Li Wang,et al.Primary Sjogren Syndrome in Han Chinese Clinical and Immunological Characteristics of 483 Patients[J].MEDICINE.2015,94(16):doi:10.1097/MD.0000000000000667.
APA:
Yun Zhao,Ya Li,Li Wang,Xiao-Feng Li,Ci-Bo Huang...&Feng-Chun Zhang.(2015).Primary Sjogren Syndrome in Han Chinese Clinical and Immunological Characteristics of 483 Patients.MEDICINE,94,(16)
MLA:
Yun Zhao,et al."Primary Sjogren Syndrome in Han Chinese Clinical and Immunological Characteristics of 483 Patients".MEDICINE 94..16(2015)